Feasibility of The Health Integrated Nutrition and Kidney Wellness Program
NCT07518719 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2026-04-09
Summary
Purpose of the Study:
This clinical trial will test whether a nutrition and kidney health program can work well for adults with kidney disease. The program was created with help from patients and community partners.
Main Questions:
How many eligible patients choose to join the program?
How many participants finish the full 12-week program?
How satisfied are participants with the program?
What Participants Will Do:
Participants will be assigned to a diet-focused lifestyle education series (THINK-Well Intervention) or enhance usual care.
THINK-Well Intervention group will take part in 7 group education sessions over 12 weeks. Sessions will be online and in-person. Topics include eating to promote heart-kidney-and metabolic health, managing long-term health conditions, setting health goals, and sharing experiences with others who have chronic disease. Participants will practice meal preparation through cooking classes and have opportunity to apply lessons on choosing whole foods with food bucks provided.
The enhanced usual care group will receive two virtual nutrition education sessions led by a trained educator over 12 weeks. Topics will be similar to standard education provided to people with kidney disease managed by a kidney doctor. Topics will be adapted from established resources from the National Kidney Foundation, American Kidney Fund, and American Heart Association.
Conditions
Interventions
- BEHAVIORAL
-
THINK-Well
Seven hybrid (online or in-person) group nutrition education sessions paired with food bucks and one individual consultation with a dietitian over 12-weeks.
- OTHER
-
Enhanced Usual Care
Two virtual group nutrition educational sessions provided by a trained educator.
Sponsors & Collaborators
- collaborator OTHER
-
University of Pittsburgh
lead OTHER
Principal Investigators
-
Linda-Marie U Lavenburg, DO, MS · University of Pittsburgh
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-29
- Primary Completion
- 2026-10-31
- Completion
- 2026-10-31
Countries
- United States
Study Locations
More Related Trials
-
Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease
NCT02791906 ·Status: TERMINATED ·Phase: PHASE2
-
A Risk Based Approach to Improving Chronic Kidney Disease Management
NCT01203813 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
NCT01101269 ·Status: TERMINATED ·Phase: NA
-
Effectiveness of a Structured Intervention to Reduce the Progression of Chronic Kidney (RENAP Study)
NCT01872468 ·Status: COMPLETED ·Phase: NA
-
The Modification of Diet in Renal Disease Study
NCT04364113 ·Status: COMPLETED ·Phase: PHASE3
-
Real World Evidence Clinical Utility Study of KidneyIntelX
NCT04802395 ·Status: RECRUITING
-
The Canadian Prevention of Renal and Cardiovascular Endpoints Trial
NCT00231803 ·Status: COMPLETED ·Phase: NA
-
Decision Impact Trial of KidneyIntelX
NCT04791358 ·Status: RECRUITING
-
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States
NCT06608212 ·Status: ACTIVE_NOT_RECRUITING
-
Pilot Study of Health Information Technology for Chronic Kidney Disease Management
NCT02990897 ·Status: COMPLETED ·Phase: NA
-
FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors
NCT07181135 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial
NCT07485075 ·Status: RECRUITING ·Phase: NA
-
Metabolomics for Identifying Biomarkers of Dietary Intake and Kidney Disease Progression
NCT03202914 ·Status: COMPLETED ·Phase: NA
-
Treatment Modification to Reduce Symptom Burden in Hemodialysis
NCT01775800 ·Status: COMPLETED ·Phase: NA
-
Chronic Kidney Disease Clinical Decision Support
NCT03890588 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis
NCT05517980 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Normal and Impaired Kidney Function
NCT04209049 ·Status: COMPLETED ·Phase: PHASE1
-
Soluble Neprilysin, NT-proBNP, and Growth-Differentiation-Factor-15 as Biomarkers for Heart Failure in Dialysis Patients
NCT04061811 ·Status: COMPLETED
-
A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function
NCT00596518 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease
NCT03579693 ·Status: COMPLETED ·Phase: PHASE2
-
Mechanism of SGLT2 Inhibition in the Kidney
NCT06291155 ·Status: RECRUITING ·Phase: PHASE4
-
Gut Microbiome and p-Inulin in CKD - TarGut CKD Study
NCT03348592 ·Status: UNKNOWN ·Phase: NA
-
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
NCT07315360 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy
NCT01712061 ·Status: COMPLETED ·Phase: PHASE2
-
Navigating the Challenges of Chronic Kidney Disease
NCT01792661 ·Status: COMPLETED ·Phase: NA